Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 12.23 as of 2026-09-12T00:15:29.230Z.
Consensus retrieved: 2026-09-11T01:04:14.809Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-12T00:15:29.230Z.
Quote observation: 2026-09-11T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7db7d2e1c63fa275e73f714870f76795ec6865cce65c567acded73c60bf598c
Forward PE Ratio (12.23) = Dated Quote Price ($181.55) / Consensus Forward EPS ($14.85)
FORWARD PE RATIO
12.23
SECTOR MEDIAN · HEALTHCARE
18.95
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-35.48%
vs the sector median at left
DaVita Inc.
Market Cap
$11.66B
Forward PE Ratio
12.23
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| DaVita Inc. (DVA) | $11.66B | 12.23 |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 35.09 |
| Encompass Health Corporation (EHC)vs › | $12.07B | 19.91 |
| Baxter International Inc. (BAX)vs › | $12.30B | 11.59 |
| Align Technology, Inc. (ALGN)vs › | $10.80B | 13.36 |
| Penumbra, Inc. (PEN)vs › | $12.52B | 67.49 |
| Molina Healthcare, Inc. (MOH)vs › | $10.66B | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 7.76 |
| The Cooper Companies, Inc. (COO)vs › | $10.51B | 11.77 |
| Tempus AI, Inc. (TEM)vs › | $10.34B | N/A |
Trailing P/E
15.9
reported TTM EPS
Forward P/E
12.2
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.85 implies +30.5% EPS growth vs the reported trailing $11.38.
At the dated quote price of $181.55, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.85 | $13.56 – $15.82 | 4 | 12.2x |
| 2027-12-31 | $17.06 | $16.82 – $17.20 | 4 | 10.6x |
| 2028-12-31 | $19.88 | $18.97 – $20.78 | 2 | 9.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
